Xiuzhen Duan Selected Research

Neoplasms (Cancer)

10/2020	Peptidylarginine deiminase 2 has potential as both a biomarker and therapeutic target of sepsis.
11/2010	Morphoproteomic analysis reveals an overexpressed and constitutively activated phospholipase D1-mTORC2 pathway in endometrial carcinoma.
9/2007	Senescence and apoptosis in carcinogenesis of cervical squamous carcinoma.
8/2004	Metastatic juxtaglomerular cell tumor in a 52-year-old man.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiuzhen Duan Research Topics

Disease

4	Sepsis (Septicemia) 01/2021 - 02/2015
4	Neoplasms (Cancer) 10/2020 - 08/2004
3	Hemorrhagic Shock 10/2020 - 01/2016
3	Acute Lung Injury 08/2018 - 04/2013
3	Carcinogenesis 04/2011 - 01/2009
2	Infections 01/2021 - 08/2018
2	Shock 01/2019 - 08/2017
2	Endotoxemia 08/2018 - 08/2013
2	Hypoxia (Hypoxemia) 01/2016 - 11/2010
2	Septic Shock (Toxic Shock Syndrome) 02/2014 - 08/2013
2	Carcinoma (Carcinomatosis) 01/2009 - 09/2007
1	Residual Neoplasm 11/2021
1	Pathologic Complete Response 11/2021
1	Breast Neoplasms (Breast Cancer) 11/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 10/2020
1	Myocardial Infarction 10/2020
1	Ischemia 10/2020
1	Wounds and Injuries (Trauma) 08/2017
1	Multiple Trauma (Multiple Injuries) 08/2017
1	Hemorrhage 01/2016
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2011
1	Lymphoma (Lymphomas) 01/2011
1	Endometrial Neoplasms (Endometrial Cancer) 11/2010
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2009
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2009
1	Uterine Cervical Dysplasia 09/2007

Drug/Important Bio-Agent (IBA)

4	Protein-Arginine DeiminasesIBA 01/2021 - 08/2018
3	LipopolysaccharidesIBA 01/2019 - 08/2013
3	Histone Deacetylase InhibitorsIBA 02/2015 - 08/2013
3	TOR Serine-Threonine KinasesIBA 04/2011 - 01/2009
2	EnzymesIBA 01/2021 - 10/2020
2	Histones (Histone)IBA 01/2019 - 08/2018
2	tubastatin AIBA 12/2018 - 01/2016
2	Histone Deacetylase 6IBA 12/2018 - 01/2016
2	Valproic Acid (Depakote)FDA LinkGeneric 08/2017 - 02/2014
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 09/2007
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2016 - 02/2015
2	Vorinostat FDA Link 02/2015 - 08/2013
2	Eosine Yellowish-(YS) (Eosin)IBA 02/2014 - 04/2013
2	Hematoxylin (Haematoxylon)IBA 02/2014 - 04/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2011 - 11/2010
2	Sirolimus (Rapamycin)FDA Link 11/2010 - 01/2009
1	Biomarkers (Surrogate Marker)IBA 10/2020
1	CalciumIBA 10/2020
1	Monoclonal AntibodiesIBA 01/2019
1	YW3-56IBA 08/2018
1	Saline SolutionIBA 08/2017
1	TubulinIBA 01/2016
1	Tight Junction ProteinsIBA 01/2016
1	Claudin-3IBA 01/2016
1	salicylhydroxamic acid (SHAM)IBA 01/2016
1	CytokinesIBA 08/2013
1	PTX3 proteinIBA 04/2013
1	MTOR InhibitorsIBA 01/2011
1	Protein Isoforms (Isoforms)IBA 11/2010
1	Mechanistic Target of Rapamycin Complex 2IBA 11/2010
1	Phospholipases (Phospholipase)IBA 11/2010
1	1-dodecylpyridoxal (PLD)IBA 11/2010
1	Phospholipase DIBA 11/2010
1	ErbB Receptors (EGF Receptor)IBA 01/2009
1	Tyrosine Kinase InhibitorsIBA 01/2009
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2009
1	Cyclin-Dependent Kinase Inhibitor p16IBA 09/2007
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 09/2007
1	ParaffinIBA 08/2004
1	Formaldehyde (Formol)FDA Link 08/2004
1	ReninIBA 08/2004
1	VimentinIBA 08/2004

Therapy/Procedure

5	Ligation 10/2020 - 08/2013
4	Punctures 12/2018 - 08/2013
2	Drug Therapy (Chemotherapy) 11/2021 - 01/2009
2	Therapeutics 11/2010 - 01/2009
1	Investigational Therapies (Experimental Therapy) 11/2021
1	Neoadjuvant Therapy 11/2021
1	Resuscitation 08/2017